Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Dow
Express Scripts
Baxter
Harvard Business School

Last Updated: December 2, 2022

Metoprolol succinate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for metoprolol succinate and what is the scope of patent protection?

Metoprolol succinate is the generic ingredient in three branded drugs marketed by Spil, Actavis Elizabeth, Actavis Labs Fl Inc, Alkem Labs Ltd, Cipla, Dr Reddys Labs Ltd, Hetero Labs Ltd Iii, Mylan Pharms Inc, Nesher Pharms, Novast Labs, Pharmadax Inc, Prinston Inc, Reddys, Sandoz, Sunshine, Visum Pharm, Wockhardt, Yichang Humanwell, Zydus Pharms, and Toprol, and is included in twenty-four NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Metoprolol succinate has eight patent family members in seven countries.

There are thirty drug master file entries for metoprolol succinate. Forty-six suppliers are listed for this compound.

Drug Prices for metoprolol succinate

See drug prices for metoprolol succinate

Drug Sales Revenue Trends for metoprolol succinate

See drug sales revenues for metoprolol succinate

Recent Clinical Trials for metoprolol succinate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Emory UniversityPhase 1/Phase 2
Hackensack Meridian HealthEarly Phase 1
University of Texas Southwestern Medical CenterN/A

See all metoprolol succinate clinical trials

Pharmacology for metoprolol succinate

US Patents and Regulatory Information for metoprolol succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt METOPROLOL SUCCINATE metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 090615-001 Jul 22, 2010 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Actavis Elizabeth METOPROLOL SUCCINATE metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 204161-004 Nov 25, 2016 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Actavis Labs Fl Inc METOPROLOL SUCCINATE metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 077298-001 Apr 15, 2010 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Visum Pharm METOPROLOL SUCCINATE metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 207206-004 Dec 19, 2018 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for metoprolol succinate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Toprol TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-001 Jan 10, 1992 See Plans and Pricing See Plans and Pricing
Toprol TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-001 Jan 10, 1992 See Plans and Pricing See Plans and Pricing
Toprol TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-001 Jan 10, 1992 See Plans and Pricing See Plans and Pricing
Toprol TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-002 Jan 10, 1992 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for metoprolol succinate

Country Patent Number Title Estimated Expiration
European Patent Office 3166599 FORME DOSIFI√ČE DE CAPSULE DE SUCCINATE DE M√ČTOPROLOL (CAPSULE DOSAGE FORM OF METOPROLOL SUCCINATE) See Plans and Pricing
World Intellectual Property Organization (WIPO) 2016005934 See Plans and Pricing
Canada 2954474 FORME DOSIFIEE DE CAPSULE DE SUCCINATE DE METOPROLOL (CAPSULE DOSAGE FORM OF METOPROLOL SUCCINATE) See Plans and Pricing
Mexico 2017000384 FORMA DE DOSIFICACION EN CAPSULAS DE SUCCINATO DE METOPROLOL. (CAPSULE DOSAGE FORM OF METOPROLOL SUCCINATE.) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
McKesson
Dow
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.